DOCKING STUDIES ON ANTIMICROBIAL PEPTIDES RELATED TO APIDAECIN- IA AND HUMAN HISTATIN AGAINST GLUTAMINE SYNTHETASE AND RNA POLYMERASE IN MYCOBACTERIUM TUBERCULOSIS
Currently need of novel molecules can be used to treat the tuberculosis including resistance multiple drug regimen (MDR) tuberculosis. Glutamine synthetase is an essential enzyme that produced the condensation reaction along with glutamate. It catalyses the glutamate react with ammonia, leads to the formation of glutamine and hydrolysis of ATP. In the brain it interact with glutamate regulation leads to detoxification ofÂ ammonia in the brain leads to termination of neurotransmitter signals. RNA polymerase catalyses the synthesis from a DNA template. It is a crucial enzyme for growth and survival of the mycobacteria. The compounds AIA-II, AIA-I were showed more potent against the Glutamine synthetase with glide score -8.79 and -7.97 as compared with standard Amikacin and Ciprofloxacin with glide score -7.71 and -3.45. The compounds AIA-I, AIA-II and HH-I were showed more potent against the RNA polymerase with glide score -10.12, -9.47 and -8.74 as compared with standard rifampicin and isoniazid with glide score -6.57 and -3.34. Â Â Â
2. McPhillie MJ, Trowbridge R, Mariner KR, Oâ€™Neill AJ, Johnson AP, Chopra I, et al. Structure-based ligand design of novel bacterial RNA polymerase inhibitors. ACS Med Chem Lett 2011 29;2:729-34.
3. Hultmark D. Drosophila immunity: Paths and patterns. Curr Opin Immunol 2003;15(1):12-9.
4. Perumal P, Pandey VP. Antimicrobial peptides: The role of hydrophobicity in the alpha helical structure. J Pharm Pharmacogn Res 2013;1:40.
5. MarÃ³ti G, Kereszt A, Kondorosi E, Mergaert P. Natural roles of antimicrobial peptides in microbes, plants and animals. Res Microbiol 2011;162(4):363-74.
6. Toke O. Antimicrobial peptides: New candidates in the fight against bacterial infections. Biopolymers 2005;80(6):717-35.
7. Rana M, Chatterjee S, Kochhar S, Pereira BM. Antimicrobial peptides: A new dawn for regulating fertility and reproductive tract infections. J Endocrinol Reprod 2006;2:88-95.
8. Rosa RD, Barraco MA. Antimicrobial peptides in crustaceans. Invertebrate Surviv J 2010;7(2):262-84.
9. Lee SB, Li B, Jin S, Daniell H. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol J 2011;9(1):100-15.
10. Mangoni ML, Shai Y. Short native antimicrobial peptides and engineered ultrashort lipopeptides: Similarities and differences in cell specificities and modes of action. Cell Mol Life Sci 2011;68(13):2267â€‘80.
11. Nissen-Meyer J, OppegÃ¥rd C, Rogne P, Haugen HS, Kristiansen PE. Structure and mode-of-action of the two-peptide (Class-IIb) bacteriocins. Probiotics Antimicrob Proteins 2010;2(1):52-60.
12. Giacometti A, Cirioni O, Greganti G, Quarta M, Scalise G. In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria. Antimicrob Agents Chemother 1998;42(12):3320-4.
13. Miyakawa Y, Ratnakar P, Rao AG, Costello ML, Mathieu-Costello O, Lehrer RI, et al. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun 1996;64(1):926-32.
14. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002;298(5595):995-1000.
15. Reddy KV, Yedery RD, Aranha C. Antimicrobial peptides: Premises and promises. Int J Antimicrob Agents 2004;24(6):536-47.
16. Paquette DW, Simpson DM, Friden P, Braman V, Williams RC. Safety and clinical effects of topical histatin gels in humans with experimental gingivitis. J Clin Periodontol 2002;29(12):1051-8.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.